Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8485391 | Vaccine | 2018 | 9 Pages |
Abstract
Overall the 2015-2016 TIV was protective against influenza infection in Beijing, with higher VE against the A(H3N2) viruses compared to A(H1N1)pdm09 and B viruses.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Li Zhang, Yang Pan, Volker Hackert, Wim van der Hoek, Adam Meijer, Thomas Krafft, Peng Yang, Quanyi Wang,